JP2018131439A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018131439A5 JP2018131439A5 JP2018021874A JP2018021874A JP2018131439A5 JP 2018131439 A5 JP2018131439 A5 JP 2018131439A5 JP 2018021874 A JP2018021874 A JP 2018021874A JP 2018021874 A JP2018021874 A JP 2018021874A JP 2018131439 A5 JP2018131439 A5 JP 2018131439A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- patient
- composition according
- compound
- infected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/431,906 US11484534B2 (en) | 2013-03-14 | 2017-02-14 | Methods for treating HCV |
| US15/431,906 | 2017-02-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018131439A JP2018131439A (ja) | 2018-08-23 |
| JP2018131439A5 true JP2018131439A5 (https=) | 2021-04-01 |
Family
ID=61192811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018021874A Pending JP2018131439A (ja) | 2017-02-14 | 2018-02-09 | Ｈｃｖを処置する方法 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP3360555A1 (https=) |
| JP (1) | JP2018131439A (https=) |
| CN (1) | CN108421029A (https=) |
| AU (1) | AU2018201011A1 (https=) |
| BR (1) | BR102018002956A2 (https=) |
| CA (1) | CA2994496A1 (https=) |
| MX (1) | MX2018001905A (https=) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0416902A (pt) * | 2003-12-11 | 2007-01-16 | Schering Corp | inibidores de ns3/ns4a serina protease do vìrus da hepatite c |
| US9394279B2 (en) | 2009-06-11 | 2016-07-19 | Abbvie Inc. | Anti-viral compounds |
| SG188618A1 (en) | 2010-09-21 | 2013-04-30 | Enanta Pharm Inc | Macrocyclic proline derived hcv serine protease inhibitors |
| SE1450131A1 (sv) | 2011-10-21 | 2014-05-07 | Abbvie Inc | DAA-kombinationsbehandling (t.ex. med ABT-072 eller ABT-333)för användning vid behandling av HCV |
| DE112012002748T5 (de) * | 2011-10-21 | 2014-07-31 | Abbvie Inc. | Verfahren zur Behandlung von HCV umfassend mindestens zwei direkt wirkende antivirale Wirkstoffe, Ribavirin aber nicht Interferon |
| RS56735B1 (sr) * | 2013-03-14 | 2018-03-30 | Abbvie Inc | Kombinacija direktno delujućih antivirusnih sredstava i ribavirina za lečenje pacijenata sa hcv |
| EP3213750B1 (en) * | 2013-03-14 | 2020-08-12 | AbbVie Inc. | Combination of two antivirals for treating hepatitis c |
| CN112891511A (zh) * | 2014-04-02 | 2021-06-04 | 艾伯维公司 | 治疗hcv的方法 |
| CA2991417A1 (en) * | 2015-07-08 | 2017-01-12 | Abbvie Inc. | Methods for treating hcv |
-
2018
- 2018-02-09 JP JP2018021874A patent/JP2018131439A/ja active Pending
- 2018-02-09 CA CA2994496A patent/CA2994496A1/en active Pending
- 2018-02-12 EP EP18156337.0A patent/EP3360555A1/en not_active Withdrawn
- 2018-02-12 AU AU2018201011A patent/AU2018201011A1/en not_active Abandoned
- 2018-02-13 CN CN201810149405.XA patent/CN108421029A/zh active Pending
- 2018-02-14 MX MX2018001905A patent/MX2018001905A/es unknown
- 2018-02-15 BR BR102018002956A patent/BR102018002956A2/pt not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2002120922A (ru) | Нуклеозидные аналоги с карбоксамидин-модифицированным моноциклическим основанием | |
| JP2004509061A5 (https=) | ||
| JP2021521118A5 (https=) | ||
| JP2014530874A5 (https=) | ||
| JP2011519364A5 (https=) | ||
| JP2021100937A5 (https=) | ||
| JP2016513703A5 (https=) | ||
| JP2013522302A5 (https=) | ||
| RU2010113976A (ru) | Применение glp-1 в качестве терапевтического средства | |
| JP2003526662A5 (https=) | ||
| RU2010114047A (ru) | Применение нейропептида af человека в качестве терапевтического средства | |
| SI2968302T1 (en) | Combination of directly-acting antiviral agents and ribavarin for the treatment of patients with HCV | |
| RU2011127080A (ru) | Производное циклоспорина для применения в лечении заражения вирусом гепатита с и вич | |
| RU2015114543A (ru) | Способы лечения гепатита с | |
| RU2005126412A (ru) | Сор1 для лечения воспалительных заболеваний кишечника | |
| RU2012136824A (ru) | Способы лечения вирусной инфекции гепатита с | |
| JP2013518124A5 (https=) | ||
| CN102083435A (zh) | 特拉匹韦给药方案 | |
| NZ588655A (en) | Treatment of hepatitis c virus infections with telaprevir (vx-950) in patients non-responsive to treatment with pegylated interfer0n-alpha-2a/2b and ribavirin | |
| RU2002112248A (ru) | Лечение вирусных инфекций с использованием левовирина | |
| JPWO2019200005A5 (https=) | ||
| JP2018131439A5 (https=) | ||
| JP2021523129A5 (https=) | ||
| RU2013120345A (ru) | Новые способы лечения инфекции, вызванной вирусом гепатита с | |
| JP2004529158A5 (https=) |